[go: up one dir, main page]

Poiley, 1987 - Google Patents

Nabumetone versus naproxen in the treatment of osteoarthritis: A six-month trial

Poiley, 1987

Document ID
4142549866878025213
Author
Poiley J
Publication year
Publication venue
The American Journal of Medicine

External Links

Snippet

The efficacy and safety of nabumetone (1,000 mg at bedtime) and naproxen (250 mg twice daily) were compared in a six-month, randomized, double-blind study of patients with osteoarthritis. Forty patients were entered in the study and completed a washout phase, and …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION

Similar Documents

Publication Publication Date Title
Clegg et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study
Weinblatt et al. Methotrexate in rheumatoid arthritis. A five‐year prospective multicenter study
Giannini et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis
Seikaly et al. Impact of alendronate on quality of life in children with osteogenesis imperfecta
Ettinger et al. Clinic Visits and Hospital Admissions for Care of Acid-Related Upper Gastrointestinal Disorders in Women
Carter et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting
Sokka et al. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Wasner et al. Nonsteroidal anti-inflammatory agents in rheumatoid arthritis and ankylosing spondylitis
US6432937B1 (en) Treatment for joint inflammation
Jacobs et al. The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: the Medi-Cal program
Mikati et al. Double‐blind randomized study comparing brand‐name and generic phenytoin monotherapy
Andrew et al. Diflunisal: six-month experience in osteoarthritis
Frame et al. A double-blind placebo-controlled comparison of three ibuprofen/codeine combinations and aspirin
Poiley Nabumetone versus naproxen in the treatment of osteoarthritis: A six-month trial
Sperling Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone
Inauen et al. Clinical Efficacy, Safety and Tolerance of Mebeverine Slow Release (200mg) vs Mebeverine Tablets in Patients with Irritable Bowel Syndrome
Appelrouth et al. Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults
Bernhard et al. Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin
Lomen et al. Flurbiprofen in the treatment of ankylosing spondylitis: a comparison with indomethacin
Evers et al. Second course gold therapy in the treatment of rheumatoid arthritis
Vasey et al. Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis: nabumetone versus naproxen double-blind parallel study
JP2023533662A (en) Rabeximod in the treatment of rheumatoid arthritis
Brown et al. Comparison of two dosing schedules of flurbiprofen for patients with rheumatoid arthritis: Twice-daily versus four-times-a-day schedules
Romatowski Comparative therapeutics of canine and human rheumatoid arthritis
Saul et al. Acemetacin and indomethacin in the treatment of rheumatoid arthritis: a double-blind comparative study in general practice